News for '-inactivated-vero-cell-platform-technology'

Bharat Biotech to manufacture 1 billion Covaxin jabs per year

Bharat Biotech on Thursday said it plans to produce additional 200 million doses of COVID-19 vaccine 'Covaxin' at its subsidiary's Ankleshwar (Gujarat) based facility, taking the overall production volume of the vaccine to 1 billion (100 crore) dosages per annum.